762 related articles for article (PubMed ID: 19489033)
1. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
[TBL] [Abstract][Full Text] [Related]
2. Suppression of bladder oxidative stress and inflammation by a phytotherapeutic agent in a rat model of partial bladder outlet obstruction.
Oka M; Fukui T; Ueda M; Tagaya M; Oyama T; Tanaka M
J Urol; 2009 Jul; 182(1):382-90. PubMed ID: 19447421
[TBL] [Abstract][Full Text] [Related]
3. The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate.
Shibuya S; Xia Z; Sugimoto M; Ueda N; Haba R; Kakehi Y
Urology; 2014 Mar; 83(3):528-34. PubMed ID: 24581515
[TBL] [Abstract][Full Text] [Related]
4. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
Sugimoto M; Oka M; Tsunemori H; Yamashita M; Kakehi Y
Prostate; 2011 Mar; 71(4):438-44. PubMed ID: 21254154
[TBL] [Abstract][Full Text] [Related]
5. Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladder-outlet obstruction: a genome-wide DNA microarray analysis.
Tagaya M; Oka M; Ueda M; Takagaki K; Tanaka M; Ohgi T; Yano J
Cytokine; 2009 Sep; 47(3):185-93. PubMed ID: 19616448
[TBL] [Abstract][Full Text] [Related]
6. Effect of the phytotherapeutic agent eviprostat on the bladder in a rat model of bladder overdistension/emptying.
Kawai Y; Oka M; Kyotani J; Oyama T; Matsumoto S; Kakizaki H
Neurourol Urodyn; 2013 Sep; 32(7):1031-7. PubMed ID: 23143863
[TBL] [Abstract][Full Text] [Related]
7. Effect of the phytotherapeutic agent Eviprostat on inflammatory changes and cytokine production in a rat model of nonbacterial prostatitis.
Tsunemori H; Sugimoto M; Xia Z; Taoka R; Oka M; Kakehi Y
Urology; 2011 Jun; 77(6):1507.e15-20. PubMed ID: 21624608
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
Wilson MJ; Woodson M; Wiehr C; Reddy A; Sinha AA
Exp Mol Pathol; 2004 Aug; 77(1):7-17. PubMed ID: 15215045
[TBL] [Abstract][Full Text] [Related]
9. Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia.
Matsumoto S; Hanai T; Matsui T; Oka M; Tanaka M; Uemura H
Phytother Res; 2010 Feb; 24(2):301-3. PubMed ID: 19585469
[TBL] [Abstract][Full Text] [Related]
10. Suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.
Matsui T; Oka M; Fukui T; Tanaka M; Oyama T; Sagawa K; Nomiya M; Yamaguchi O
Int J Urol; 2012 Jul; 19(7):669-75. PubMed ID: 22458726
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
Said MM; Bosland MC
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
[TBL] [Abstract][Full Text] [Related]
12. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
[TBL] [Abstract][Full Text] [Related]
13. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
Iwamura H; Koie T; Soma O; Matsumoto T; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Ohyama C
BMC Urol; 2015 Dec; 15():120. PubMed ID: 26643109
[TBL] [Abstract][Full Text] [Related]
14. [Effects of cernitin pollen-extract (Cernilton) on inflammatory cytokines in sex-hormone-induced nonbacterial prostatitis rats].
Asakawa K; Nandachi N; Satoh S; Honma M; Namikata S; Ishii M; Yasumoto R; Nishisaka N; Masuda C; Kishimoto T
Hinyokika Kiyo; 2001 Jul; 47(7):459-65. PubMed ID: 11523128
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms by which a phytotherapeutic drug influences bladder activity in rats.
Sugaya K; Nishijima S; Tasaki S; Kadekawa K; Miyazato M; Ogawa Y
J Urol; 2008 Feb; 179(2):770-4. PubMed ID: 18082195
[TBL] [Abstract][Full Text] [Related]
16. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
Int J Urol; 2004 Jul; 11(7):501-9. PubMed ID: 15242359
[TBL] [Abstract][Full Text] [Related]
17. Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis.
Nasrin S; Masuda E; Kugaya H; Ito Y; Yamada S
J Urol; 2013 Mar; 189(3):1123-9. PubMed ID: 23000860
[TBL] [Abstract][Full Text] [Related]
18. The soy effect in the disease models of nonbacterial prostatitis and obstructive voiding.
Yatkin E; Streng T; Kauppila ML; Bernoulli J; Saarinen N; Santti R
Exp Biol Med (Maywood); 2007 May; 232(5):674-81. PubMed ID: 17463164
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
Yatkin E; Bernoulli J; Talvitie EM; Santti R
Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model.
Sohn DW; Han CH; Jung YS; Kim SI; Kim SW; Cho YH
Int J Antimicrob Agents; 2009 Sep; 34(3):215-9. PubMed ID: 19375896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]